Sanofi eyes bigger play in fast-growing Indian consumer healthcare market
This article was originally published in Scrip
Executive Summary
Sanofi India appears keen to raise its profile in the fast growing Indian consumer healthcare segment, dovetailing synergies from its nutraceuticals portfolio acquired earlier from Universal Medicare and a clutch of high potential over-the-counter (OTC) products including the just launched Combiflam Plus (paracetamol plus caffeine).